Ignite Creation Date:
2024-05-05 @ 5:29 PM
Last Modification Date:
2024-10-26 @ 9:32 AM
Study NCT ID:
NCT00463242
Status:
COMPLETED
Last Update Posted:
2020-12-23
First Post:
2007-04-19
Brief Title:
A Placebo- and Paroxetine-controlled Study of the Efficacy Safety and Tolerability of Agomelatine 25 or 50 mg in the Treatment of Major Depressive Disorder MDD
Sponsor:
Novartis
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-03
Start Date Type:
None
Primary Completion Date:
2008-06
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2007-04-19
First Submit QC Date:
April 19 2007
Study First Post Date:
2007-04-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2012-05-02
Disp First Submit QC Date:
May 2 2012
Disp First Post Date:
2012-05-04
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2020-12-15
Last Update Post Date:
2020-12-23
Last Update Post Date Type:
ACTUAL